The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mast cells as mediators of fibrosis and effector cell recruitment in dermal chronic graft-versus-host disease.
 
Ethan Strattan
No Relationships to Disclose
 
Senthilnathan Palaniyandi
No Relationships to Disclose
 
Reena Kumari
No Relationships to Disclose
 
Jing Du
No Relationships to Disclose
 
Timothy Huang
No Relationships to Disclose
 
Melissa Kesler
No Relationships to Disclose
 
Jamie Sturgill
No Relationships to Disclose
 
Gerhard Hildebrandt
Stock and Other Ownership Interests - Abbvie; Aetna; Axim Biotechnologies; Bluebird Bio; Bristol-Myers Squibb/Medarex; Cardinal Health; Celgene; Cellectis; Clovis Oncology; crispr therapeutics; CVS Health; Endocyte; GW Pharmaceuticals; IDEXX Laboratories; Immunomedics; Insys Therapeutics; Johnson & Johnson; Juno Therapeutics; Kite, a Gilead company; Novartis; Pfizer; Procter & Gamble; Sangamo Bioscience; Vertex
Consulting or Advisory Role - Incyte; Incyte; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Kite, a Gilead company; Pfizer
Research Funding - Jazz Pharmaceuticals; Pharmacyclics; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; Falk Foundation; Incyte; Jazz Pharmaceuticals; Kite, a Gilead company; Pfizer